Amyloid-β and tau proteins are involved in the progression of Alzheimer’s disease (AD), while α-, β- and γ-synucleins are associated with Parkinson’s disease (PD) [2,3,4,24]. This evidence concerns the gene MAPT and Parkinson disease.